Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04105270 |
Title | P2 of RMT in Combo w Durvalumab or Durva + Chemo in Untreated Adenocarcinoma NSCLC |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Masonic Cancer Center, University of Minnesota |
Indications | |
Therapies |
Carboplatin + Durvalumab + Pemetrexed Disodium |
Age Groups: | adult | senior |
Covered Countries | USA |